Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

Kilroy Realty has opened a second phase of its Oyster Point life sciences campus — but it's attracting financial and tech ...

The next phase of Kilroy's big Oyster Point project is seeing interest from tech and financial services as well as biotech, long the dominant industry in South San Francisco.

Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology firm specializing in regenerative medicine with a market capitalization of approximately $7 million, has revealed promising one-year follow-up ...

LYON, France, Feb. 11, 2025 /CNW/ -- Ziwig, a French biotech company committed to advancing women's health, announces the ...

HongShan Capital Group —one of the largest private Chinese players with USD 55 billion under management, and a backer of fast ...

PLC (NASDAQ: TCBP), a biotechnology firm with a market capitalization of $33.08 million engaged in developing gamma-delta T cell therapies, announced today significant progress in its ACHIEVE Phase 2B ...

Global X MLP & Energy Infrastructure ETF and Alerian differ in focus and performance. Read why MLPX and AMLP appeal to ...